Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
38°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
117.31
-5.38 (-4.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Moderna Announces Changes to Commercial Organization to Prepare for Multiple Product Launches in 2024 and 2025
December 12, 2023
Via
ACCESSWIRE
Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer
December 11, 2023
From
Merck & Co., Inc.
Via
Business Wire
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
December 07, 2023
Via
ACCESSWIRE
Upwork underscores the strength of the AI gig economy
November 28, 2023
Upwork has been pursuing its goal of being the world's preeminent destination for artificial intelligence (AI) related talent and freelancers
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Moderna to Present at Upcoming Conferences in November 2023
November 08, 2023
Via
ACCESSWIRE
Moderna Highlights its Digital and AI Strategy and Progress at Second Digital Investor Event
November 08, 2023
Via
ACCESSWIRE
Moderna Tops BioSpace’s Best Places to Work Ranking for Third Consecutive Year
November 07, 2023
Via
ACCESSWIRE
Moderna to Host Second Environmental, Social and Governance (ESG) Investor Event on December 7th, 2023
November 14, 2023
Via
ACCESSWIRE
Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 02, 2023
Via
ACCESSWIRE
CEPI and Moderna Harness mRNA Technology to Advance 100 Days Mission
October 30, 2023
Via
ACCESSWIRE
Moderna Named a Top Employer by Science for Ninth Consecutive Year
October 26, 2023
Via
ACCESSWIRE
Moderna Announces First Participant Dosed in Phase 3 Study of mRNA-1083, a Combination Vaccine Against Influenza and COVID-19
October 24, 2023
Via
ACCESSWIRE
Moderna to Host Second Digital Investor Event on November 8th, 2023
October 19, 2023
Via
ACCESSWIRE
Moderna Inc. (NASDAQ: MRNA) Making Surprising Moves in Wednesday Session
September 13, 2023
Via
Investor Brand Network
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
September 11, 2023
Via
ACCESSWIRE
Moderna to Host Investor Event - R&D Day and Business Updates
August 30, 2023
Via
ACCESSWIRE
Moderna Inc. (NASDAQ: MRNA) Highlighted for Surprising Price Action
August 21, 2023
Via
Investor Brand Network
Moderna to Report Third Quarter 2023 Financial Results on Thursday, November 2, 2023
October 12, 2023
Via
ACCESSWIRE
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
October 06, 2023
As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth.
Via
MarketBeat
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19
October 04, 2023
Via
ACCESSWIRE
Moderna Recommends Shareholders Reject Amended “Mini-Tender” Offer by TRC Capital Investment Corporation
September 29, 2023
Via
ACCESSWIRE
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union
September 14, 2023
Via
ACCESSWIRE
Moderna Inc. (NASDAQ: MRNA) is a Leading Gainer in 8/17 Morning Trading
August 17, 2023
Via
Investor Brand Network
Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 03, 2023
Via
ACCESSWIRE
Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease
September 13, 2023
Via
ACCESSWIRE
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
September 11, 2023
Via
ACCESSWIRE
Moderna Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
September 08, 2023
Via
ACCESSWIRE
Moderna to Participate at Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
Via
ACCESSWIRE
Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86
September 06, 2023
Via
ACCESSWIRE
Moderna Clinical Trial Data Confirm Its Updated COVID-19 Vaccine Generates Robust Immune Response in Humans Against Widely Circulating Variants
August 17, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.